Acceleris Capital
Other
Active
Manchester, United Kingdom
18
2M
13
0.75
2
0.28
6
- Areas of investment
Summary
Acceleris Capital is the famous VC, which was founded in 2000. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the Manchester.
The current fund was established by Norman Molyneux. The overall number of key employees were 2.
The fund is generally included in less than 2 deals every year. Opposing the other organizations, this Acceleris Capital works on 11 percentage points less the average amount of lead investments. The important activity for fund was in 2017. Speaking about the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2015. The common things for fund are deals in the range of 1 - 5 millions dollars.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Acceleris Capital, startups are often financed by Enterprise Ventures, Development Bank of Wales, The Welsh Government. The meaningful sponsors for the fund in investment in the same round are Seneca Partners, Development Bank of Wales, Enterprise Ventures. In the next rounds fund is usually obtained by Development Bank of Wales, Seneca Partners, UK Innovation & Science Seed Fund.
Among the most popular portfolio startups of the fund, we may highlight Evgen Pharma, Redag Crop Protection, Femeda. Among the most successful fund investment fields, there are Health Care, Chemical. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 2
- Exits
- 6
- Rounds per year
- 0.75
- Follow on index
- 0.28
- Investments by industry
- Biotechnology (8)
- Health Care (6)
- Pharmaceutical (5)
- Manufacturing (4)
- Chemical (4) Show 16 more
- Investments by region
-
- United Kingdom (16)
- United States (1)
- Singapore (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 8M
- Group Appearance index
- 0.72
- Avg. company exit year
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Microvisk Technologies | 01 Jan 2006 | Health Care, Manufacturing, Medical Device | Early Stage Venture | Wales, St Asaph, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.